FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

Related Content:

Bio/Pharma BusinessFormulation and Drug DeliveryManufacturingDosage Forms

CordenPharma and Viking Therapeutics to Partner for Integrated Supply of GLP-1s

Accelerating Adoption of Smart Tools to Advance Manufacturing

FDA Approves First Generics of Rivaroxaban Tablets